FutureCeuticals Embarks on New Research for Bone-, Joint-Health Calcium Fructoborate

August 30, 2011

FutureCeuticals says that part of the research will focus on differentiating calcium fructoborate from other boron-based compounds and borate complexes.

FutureCeuticals Inc. (Momence, IL) is partnering with BioBoron Research Institute to study FruiteX-B, FutureCeuticals’ branded, nature-identical calcium fructoborate ingredient. Calcium fructoborate is believed to offer benefits for bone and joint health, including the ability to modulate inflammatory and lipid blood markers in osteoarthritis sufferers.

FutureCeuticals says that part of the research will focus on differentiating calcium fructoborate from other boron-based compounds and borate complexes.

Related Content:

Joint & Bone Health